Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination in Patients With Cystic Fibrosis and, Where Applicable, the Clinical Expression of Influenza A (H1N1). [Etude de cohorte evaluant l'efficacite clinique, la tolerance et l'immunogenicite a la vaccination antigrippale pandemique chez les patients atteints de mucoviscidose et, le cas echeant, l'expression clinique de la grippe A (H1N1) et les facteurs associes a la survenue de formes severes dans cette population.]

Next Previous
Trial Profile

Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza Vaccination in Patients With Cystic Fibrosis and, Where Applicable, the Clinical Expression of Influenza A (H1N1). [Etude de cohorte evaluant l'efficacite clinique, la tolerance et l'immunogenicite a la vaccination antigrippale pandemique chez les patients atteints de mucoviscidose et, le cas echeant, l'expression clinique de la grippe A (H1N1) et les facteurs associes a la survenue de formes severes dans cette population.]

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Sep 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Influenza A virus vaccine-H1N1 (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Pharmacogenomic; Therapeutic Use
  • Acronyms MUCOFLU

Most Recent Events

  • 26 Aug 2014 Biomarkers information updated
  • 14 Sep 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.
  • 21 Dec 2011 Additional lead trial centre ( Assistance Publique - Hopitaux de Paris) and investigator (Isabelle Sermet) identified as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top